Friday, July 12, 2019 12:00:42 AM
What is Nasdaq's compliance process for companies failing to meet the $1.00 minimum bid price requirement?
If a company trades for 30 consecutive business days below the $1.00 minimum closing bid price requirement, Nasdaq will send a deficiency notice to the company, advising that it has been afforded a "compliance period" of 180 calendar days to regain compliance with the applicable requirements.
Thereafter, if such a company does not regain compliance with the bid price requirement a second 180-day compliance period may be available. A company listed on the Nasdaq Capital Market may be eligible for an additional 180-day compliance period if it meets the market value of publicly held shares requirement for continued listing, all other initial inclusion requirements for the Capital Market, except for the bid price requirement, and provides written notice that it intends to regain compliance with the bid price requirement during the second 180-day compliance period, by effecting a reverse stock split if necessary.
Similarly, if a company listed on the Nasdaq Global Select Market or Global Market company is unable to comply with the bid price requirement prior to the expiration of its 180-day compliance period, it may transfer to the Nasdaq Capital Market, so as to take advantage of the additional compliance period offered on that market. Such a company must meet the $1 million market value of publicly held shares requirement for continued listing, and all other requirements for initial listing on the Nasdaq Capital Market (except for the bid price requirement), and provide written notice that it intends to regain compliance with the bid price requirement during the second 180-day compliance period, by effecting a reverse stock split if necessary. If a company does not indicate its intent to cure the deficiency, or if it does not appear to Nasdaq that it is possible for the company to cure the deficiency, the company will not be eligible for the second compliance period.
A Nasdaq Global or Global Select Market company that is in the Hearings Process for the minimum $1.00 bid price requirement can submit a transfer application ONLY if it meets the continued listing requirement for market value of publicly held shares and all other initial listing criteria (except initial bid price) for the Capital Market. If the application is approved, the company's securities will be transferred to the Capital Market. The company will be granted the balance of the second 180-day compliance period to resolve its $1.00 bid price deficiency.
Source
Recent ALTO News
- Alto’s Magic Valley Facility Production Rate Consistently Achieving Full Capacity • GlobeNewswire Inc. • 10/15/2024 12:30:29 PM
- Alto Ingredients, Inc. to Present in the 26th Annual H.C. Wainwright Global Investment Conference • GlobeNewswire Inc. • 09/03/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:35:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:21:10 PM
- Alto Ingredients, Inc. Reports Second Quarter 2024 Results • GlobeNewswire Inc. • 08/06/2024 08:05:20 PM
- Alto Ingredients, Inc. to Release Second Quarter 2024 Financial Results on August 6, 2024 • GlobeNewswire Inc. • 07/30/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:15:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:13:30 PM
- Alto Ingredients, Inc. Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/06/2024 08:05:21 PM
- Alto Ingredients, Inc. to Release First Quarter 2024 Financial Results on May 6, 2024 • GlobeNewswire Inc. • 04/29/2024 12:30:15 PM
- Alto Ingredients, Inc. Appoints Todd E. Benton as Chief Operating Officer; Michael D. Kandris to Continue to Serve as Director • GlobeNewswire Inc. • 03/21/2024 12:30:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:18:04 PM
- Alto Ingredients, Inc. Reports Fourth Quarter and Year-end 2023 Results • GlobeNewswire Inc. • 03/11/2024 08:05:08 PM
- Alto Ingredients, Inc. Enters Letter of Intent with Vault to Advance Carbon Capture and Storage Initiative • GlobeNewswire Inc. • 03/11/2024 08:02:21 PM
- Alto Ingredients, Inc. to Participate in the 36th Annual Roth Conference • GlobeNewswire Inc. • 03/05/2024 01:30:06 PM
- Alto Ingredients, Inc. to Release Fourth Quarter 2023 Financial Results • GlobeNewswire Inc. • 03/04/2024 01:30:24 PM
- Alto Ingredients, Inc. Publishes Sustainability Summary • GlobeNewswire Inc. • 12/11/2023 01:30:04 PM
- Alto Ingredients, Inc. Extends Term Loan Commitment Period • GlobeNewswire Inc. • 12/06/2023 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:32:32 PM
- Alto Ingredients, Inc. to Participate in Upcoming Conferences • GlobeNewswire Inc. • 11/08/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 09:19:10 PM
- Alto Ingredients, Inc. Reports Third Quarter 2023 Results • GlobeNewswire Inc. • 11/06/2023 09:05:29 PM
- Alto Ingredients, Inc. to Release Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 10/30/2023 12:30:00 PM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM